IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v50y1999i1-2p1-22.html
   My bibliography  Save this article

Priority setting in health policy in Sweden and a comparison with Norway

Author

Listed:
  • Calltorp, Johan

Abstract

No abstract is available for this item.

Suggested Citation

  • Calltorp, Johan, 1999. "Priority setting in health policy in Sweden and a comparison with Norway," Health Policy, Elsevier, vol. 50(1-2), pages 1-22, December.
    • Handle: RePEc:eee:hepoli:v:50:y:1999:i:1-2:p:1-22
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(99)00061-5
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Lundberg, Lena & Johannesson, Magnus & Isacson, Dag G. L. & Borgquist, Lars, 1998. "Effects of user charges on the use of prescription medicines in different socio-economic groups," Health Policy, Elsevier, vol. 44(2), pages 123-134, May.
    2. Anell, Anders & Rosen, Per & Hjortsberg, Catharina, 1997. "Choice and participation in the health services: a survey of preferences among swedish residents," Health Policy, Elsevier, vol. 40(2), pages 157-168, May.
    3. Hanning, Marianne, 1996. "Maximum waiting-time guarantee -- an attempt to reduce waiting lists in Sweden," Health Policy, Elsevier, vol. 36(1), pages 17-35, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jang, Sung-In & Nam, Jung-Mo & Choi, Jongwon & Park, Eun-Cheol, 2014. "Disease management index of potential years of life lost as a tool for setting priorities in national disease control using OECD health data," Health Policy, Elsevier, vol. 115(1), pages 92-99.
    2. Kaukonen, Pälvi & Salmelin, Raili K. & Luoma, Ilona & Puura, Kaija & Rutanen, Mervi & Pukuri, Tarja & Tamminen, Tuula, 2010. "Child psychiatry in the Finnish health care reform: National criteria for treatment access," Health Policy, Elsevier, vol. 96(1), pages 20-27, June.
    3. Golan, Ofra & Hansen, Paul & Kaplan, Giora & Tal, Orna, 2011. "Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights?," Health Policy, Elsevier, vol. 102(2), pages 126-135.
    4. Ottersen, Trygve & Førde, Reidun & Kakad, Meetali & Kjellevold, Alice & Melberg, Hans Olav & Moen, Atle & Ringard, Ånen & Norheim, Ole Frithjof, 2016. "A new proposal for priority setting in Norway: Open and fair," Health Policy, Elsevier, vol. 120(3), pages 246-251.
    5. Aris Angelis & Ansgar Lange & Panos Kanavos, 2018. "Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 123-152, January.
    6. Haeder, Simon F., 2014. "Balancing adequacy and affordability?: Essential Health Benefits under the Affordable Care Act," Health Policy, Elsevier, vol. 118(3), pages 285-291.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jonsson, Pia Maria & Schmidt, Ingrid & Sparring, Vibeke & Tomson, Goran, 2006. "Gender equity in health care in Sweden--Minor improvements since the 1990s," Health Policy, Elsevier, vol. 77(1), pages 24-36, June.
    2. Vincenzo Atella & Joanna Kopinska, 2014. "The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regression," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 59(2), pages 329-339, April.
    3. Jiménez-Rubio, Dolores & Hernández-Quevedo, Cristina, 2010. "Explaining the demand for pharmaceuticals in Spain: Are there differences in drug consumption between foreigners and the Spanish population?," Health Policy, Elsevier, vol. 97(2-3), pages 217-224, October.
    4. Stéphanie Boulenger & François Vaillancourt, 2013. "Temps d'attente dans le secteur public de la santé au Québec : mesure, conséquences et moyens pour les réduire," CIRANO Project Reports 2013rp-17, CIRANO.
    5. Rotstein, Dalia L. & Alter, David A., 2006. "Where does the waiting list begin? A short review of the dynamics and organization of modern waiting lists," Social Science & Medicine, Elsevier, vol. 62(12), pages 3157-3160, June.
    6. Sarma, Sisira & Basu, Kisalaya & Gupta, Anil, 2007. "The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada," Social Science & Medicine, Elsevier, vol. 65(12), pages 2553-2565, December.
    7. Creemers, Stefan & Beliën, Jeroen & Lambrecht, Marc, 2012. "The optimal allocation of server time slots over different classes of patients," European Journal of Operational Research, Elsevier, vol. 219(3), pages 508-521.
    8. Propper, Carol & Croxson, Bronwyn & Shearer, Arran, 2002. "Waiting times for hospital admissions: the impact of GP fundholding," Journal of Health Economics, Elsevier, vol. 21(2), pages 227-252, March.
    9. Harrison, Michael I. & Calltorp, Johan, 2000. "The reorientation of market-oriented reforms in Swedish health-care," Health Policy, Elsevier, vol. 50(3), pages 219-240, January.
    10. W.B.F. Brouwer & F.T. Schut, 1999. "Priority care for employees: A blessing in disguise?," Health Economics, John Wiley & Sons, Ltd., vol. 8(1), pages 65-73, February.
    11. Hjelmgren, Jonas & Anell, Anders, 2007. "Population preferences and choice of primary care models: A discrete choice experiment in Sweden," Health Policy, Elsevier, vol. 83(2-3), pages 314-322, October.
    12. Brouwer, Werner B. F. & Hermans, Herbert E. G. M., 1999. "Private clinics for employees as a Dutch solution for waiting lists: economic and legal arguments," Health Policy, Elsevier, vol. 47(1), pages 1-17, April.
    13. Anders Anell, 2005. "Swedish healthcare under pressure," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 237-254, September.
    14. Lapidus, John, 2017. "Private health insurance in Sweden: Fast-track lanes and the alleged attempts to stop them," Health Policy, Elsevier, vol. 121(4), pages 442-449.
    15. Noyce, Peter R. & Huttin, Christine & Atella, Vicenzo & Brenner, Gerhard & Haaijer-Ruskamp, Flora M. & Hedvall, Maj-Britt & Mechtler, Reli, 2000. "The cost of prescription medicines to patients," Health Policy, Elsevier, vol. 52(2), pages 129-145, June.
    16. Glenngård, Anna H. & Anell, Anders & Beckman, Anders, 2011. "Choice of primary care provider: Results from a population survey in three Swedish counties," Health Policy, Elsevier, vol. 103(1), pages 31-37.
    17. Vincenzo Atella & Franco Peracchi & Domenico Depalo & Claudio Rossetti, 2006. "Drug compliance, co‐payment and health outcomes: evidence from a panel of Italian patients," Health Economics, John Wiley & Sons, Ltd., vol. 15(9), pages 875-892, September.
    18. Hanning, Marianne & Spangberg, Ulrika Winblad, 2000. "Maximum waiting time -- a threat to clinical freedom?: Implementation of a policy to reduce waiting times," Health Policy, Elsevier, vol. 52(1), pages 15-32, May.
    19. Vincenzo Atella & Karen Hassell & Ellen Schafheutle & Marjorie C. Weiss & Peter R. Noyce, 2003. "Cost to the Patient or Cost to the Healthcare System? Which one Matters the Most for GP Prescribing Decisions? A UK-Italy Comparison," CEIS Research Paper 1, Tor Vergata University, CEIS.
    20. Forsberg, Ewa & Axelsson, Runo & Arnetz, Bengt, 2001. "Financial incentives in health care. The impact of performance-based reimbursement," Health Policy, Elsevier, vol. 58(3), pages 243-262, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:50:y:1999:i:1-2:p:1-22. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.